Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City

References

• Abadie, R., Goldenberg, S., Welch-Lazoritz, M., & Fisher, C. B. (2018). Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research. PLoS One, 13(12), e0208410. https://doi.org/10.1371/journal.pone.0208410
   PubMed Web of Science ®Google Scholar
• Ahern, J., Stuber, J., & Galea, S. (2007). Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend, 88(2-3), 188–196. https://doi.org/10.1016/j.drugalcdep.2006.10.014
   PubMed Web of Science ®Google Scholar
• Arasteh, K., Des Jarlais, D. C., Feelemyer, J., & McKnight, C. (2020). Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York City. Global Public Health, 15(12), 1789–1799. https://doi.org/10.1080/17441692.2020.1768276
   PubMed Web of Science ®Google Scholar
• Behrends, C. N., Nugent, A. V., Des Jarlais, D. C., Frimpong, J. A., Perlman, D. C., & Schackman, B. R. (2018). Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. Journal of Acquired Immune Deficiency Syndromes (1999), 79(2), e76–e78. https://doi.org/10.1097/QAI.0000000000001792
   PubMed Web of Science ®Google Scholar
• Biancarelli, D. L., Biello, K. B., Childs, E., Drainoni, M., Salhaney, P., Edeza, A., Mimiaga, M. J., Saitz, R., & Bazzi, A. R. (2019). Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug and Alcohol Dependence, 198, 80–86. https://doi.org/10.1016/j.drugalcdep.2019.01.037
   PubMed Web of Science ®Google Scholar
• Bull-Otterson, L., Huang, Y.-L A., Zhu, W., King, H., Edlin, B. R., & Hoover, K. W. (2020). Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States. The Journal of Infectious Diseases, 222(6), 940–2017. https://doi.org/10.1093/infdis/jiaa017
   PubMed Web of Science ®Google Scholar
• Butner, J. L., Gupta, N., Fabian, C., Henry, S., Shi, J. M., & Tetrault, J. M. (2017). Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program. Journal of Substance Abuse Treatment, 75, 49–53. https://doi.org/10.1016/j.jsat.2016.12.014
   PubMed Web of Science ®Google Scholar
• Cano, M. (2020). Drug Overdose Deaths Among US Hispanics: Trends (2000-2017) and Recent Patterns. Substance Use & Misuse, 55(13), 2138–2147. https://doi.org/10.1080/10826084.2020.1793367
   PubMed Web of Science ®Google Scholar
• Carey, K. J., Huang, W., Linas, B. P., & Tsui, J. I. (2016). Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders. Journal of Substance Abuse Treatment, 66, 54–59. https://doi.org/10.1016/j.jsat.2016.01.009
   PubMed Web of Science ®Google Scholar
• CDC. (2019). Viral Hepatitis Surveillance United States, 2017. Centers for Disease Control and Prevention. Retrieved May 15, 2020 from https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm
   Google Scholar
• Charmaz, K. (2006). Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis. Sage.
   Google Scholar
• Day, E., Broder, T., Bruneau, J., Cruse, S., Dickie, M., Fish, S., Grillon, C., Luhmann, N., Mason, K., McLean, E., Trooskin, S., Treloar, C., & Grebely, J. (2019). Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs. The International Journal on Drug Policy, 66, 87–93. https://doi.org/10.1016/j.drugpo.2019.01.012
   PubMed Web of Science ®Google Scholar
• DeCuir, J., Lovasi, G. S., El-Sayed, A., & Lewis, C. F. (2018). The association between neighborhood socioeconomic disadvantage and high-risk injection behavior among people who inject drugs. Drug and Alcohol Dependence, 183, 184–191. https://doi.org/10.1016/j.drugalcdep.2017.10.025
   PubMed Web of Science ®Google Scholar
• Earnshaw, V. A., & Quinn, D. M. (2012). The impact of stigma in healthcare on people living with chronic illnesses. Journal of Health Psychology, 17(2), 157–168. https://doi.org/10.1177/1359105311414952
   PubMed Web of Science ®Google Scholar
• Eckhardt, B., Aponte-Meledez, Y., Fung, C., Kapadia, S., Davis, L., Smith, M., Mateu-Gelabert, P., & Marks, K. (2019). 297. Accessible Care Intervention for Engaging People Who Inject Illicit Drugs in Hepatitis C Virus Care: Preliminary Results from a Randomized Clinical Trial. Open Forum Infectious Diseases, 6(Supplement_2), S161–S161. https://doi.org/10.1093/ofid/ofz360.372
   Google Scholar
• Eckhardt, B. J., Scherer, M., Winkelstein, E., Marks, K., & Edlin, B. R. (2018). Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program. Open Forum Infect Dis, 5(4), 1–4. https://doi.org/https://doi.org/10.1093/ofid/ofy048
   Web of Science ®Google Scholar
• Ford, M. M., Jordan, A. E., Johnson, N., Rude, E., Laraque, F., Varma, J. K., & Hagan, H. (2018). Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations. Journal of Public Health Management and Practice: JPHMP, 24(1), 41–48. https://doi.org/10.1097/PHH.0000000000000519
   PubMed Web of Science ®Google Scholar
• Ford, K., Wirawan, D. N., Sumantera, G. M., Sawitri, A. A., & Stahre, M. (2004). Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Education and Prevention : official Publication of the International Society for AIDS Education, 16(6), 487–498. https://doi.org/10.1521/aeap.16.6.487.53789
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Pouget, E. R., Sandoval, M., Rossi, D., Mateu-Gelabert, P., Nikolopoulos, G. K., Schneider, J. A., Smyrnov, P., & Stall, R. D. (2017). Interpersonal Attacks on the Dignity of Members of HIV Key Populations: A Descriptive and Exploratory Study. AIDS and Behavior, 21(9), 2561–2578. https://doi.org/10.1007/s10461-016-1578-4
   PubMed Web of Science ®Google Scholar
• Gaudino, A., Gay, B., Garmon, C., Selick, M., Vreeland, R., Burk, K., Huriaux, E., Facente, S. N., Luetkemeyer, A., Waters, P., & Graham, C. S. (2018). Localized US Efforts to Eliminate Hepatitis C. Infectious Disease Clinics of North America, 32(2), 293–311. https://doi.org/10.1016/j.idc.2018.02.009
   PubMed Web of Science ®Google Scholar
• Gelpí-Acosta, C., Rodríguez-Díaz, C. E., Aponte-Meléndez, Y., & Abadie, R. (2020). Puerto Rican Syndemics: Opiates, Overdoses, HIV, and the Hepatitis C Virus in a Context of Ongoing Crises. American Journal of Public Health, 110(2), 176–177. https://doi.org/10.2105/AJPH.2019.305487
   PubMed Web of Science ®Google Scholar
• Ginoza, M. E. C., Tomita-Barber, J., Onugha, J., Bullock, C., Bartholomew, T. S., Tookes, H. E., & Serota, D. P. (2020). Student-Run Free Clinic at a Syringe Services Program, Miami, Florida, 2017–2019. American Journal of Public Health, 110(7), 988–990. https://doi.org/10.2105/AJPH.2020.305705
   PubMed Web of Science ®Google Scholar
• Glick, S. N., Prohaska, S. M., LaKosky, P. A., Juarez, A. M., Corcorran, M. A., & Des Jarlais, D. C. (2020). The Impact of COVID-19 on Syringe Services Programs in the United States. AIDS and Behavior, 24(9), 2466–2468. https://doi.org/10.1007/s10461-020-02886-2
   PubMed Web of Science ®Google Scholar
• Goffman, E. (1963). Stigma; notes on the management of spoiled identity. Prentice-Hall.
   Google Scholar
• Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011). A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. The Journal of Infectious Diseases, 204(1), 74–83. https://doi.org/10.1093/infdis/jir196
   PubMed Web of Science ®Google Scholar
• Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2019). Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016. Hepatology (Baltimore, Md.), 69(3), 1020–1031. https://doi.org/10.1002/hep.30297
   PubMed Web of Science ®Google Scholar
• Jenkins, W. D., Bolinski, R., Bresett, J., Van Ham, B., Fletcher, S., Walters, S., Friedman, S. R., Ezell, J. M., Pho, M., Schneider, J., & Ouellet, L. (2020). COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities. J Rural Health, 37(1), 172–174. https://doi.org/10.1111/jrh.12442
   PubMed Web of Science ®Google Scholar
• Jordan, A. E., Cleland, C. M., Wyka, K., Schackman, B. R., Perlman, D. C., & Nash, D. (2020). Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City. The Journal of Infectious Diseases, 222(Supplement_5), S322–S334. https://doi.org/10.1093/infdis/jiz659
   PubMedGoogle Scholar
• Jordan, A. E., Des Jarlais, D. C., Arasteh, K., McKnight, C., Nash, D., & Perlman, D. C. (2015). Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. Drug and Alcohol Dependence, 152, 194–200. https://doi.org/10.1016/j.drugalcdep.2015.03.039
   PubMed Web of Science ®Google Scholar
• Jordan, A. E., Masson, C. L., Mateu-Gelabert, P., McKnight, C., Pepper, N., Bouche, K., Guzman, L., Kletter, E., Seewald, R. M., Des-Jarlais, D. C., Sorensen, J. L., & Perlman, D. C. (2013). Perceptions of drug users regarding hepatitis C screening and care: A qualitative study. Harm Reduction Journal, 10(10), 10. https://doi.org/10.1186/1477-7517-10-10
   PubMedGoogle Scholar
• Jordan, A. E., Perlman, D. C., Cleland, C. M., Wyka, K., Schackman, B. R., & Nash, D. (2020). Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation. J Clin Virol, 124, 104285. https://doi.org/10.1016/j.jcv.2020.104285
   PubMed Web of Science ®Google Scholar
• Kaiser, K. (2009). Protecting respondent confidentiality in qualitative research. Qual Health Res, 19(11), 1632–1641. https://doi.org/10.1177/1049732309350879
   PubMed Web of Science ®Google Scholar
• Kolla, G., Strike, C., Watson, T. M., Jairam, J., Fischer, B., & Bayoumi, A. M. (2017). Risk creating and risk reducing: Community perceptions of supervised consumption facilities for illicit drug use. Health, Risk & Society, 19(1-2), 91–111. https://doi.org/10.1080/13698575.2017.1291918
   Web of Science ®Google Scholar
• Krieger, N. (2012). Methods for the scientific study of discrimination and health: An ecosocial approach. American Journal of Public Health, 102(5), 936–944. https://doi.org/10.2105/AJPH.2011.300544
   PubMed Web of Science ®Google Scholar
• Link, B. G., & Phelan, J. C. (2001). Conceptualizing Stigma. Annual Review of Sociology, 27, 363–385.
   Google Scholar
• Luoma, J. B., Twohig, M. P., Waltz, T., Hayes, S. C., Roget, N., Padilla, M., & Fisher, G. (2007). An investigation of stigma in individuals receiving treatment for substance abuse. Addictive Behaviors, 32(7), 1331–1346. https://doi.org/10.1016/j.addbeh.2006.09.008
   PubMed Web of Science ®Google Scholar
• Martin, S. A., Bosse, J., Wilson, A., Losikoff, P., & Chiodo, L. (2018). Under one roof: Identification, evaluation, and treatment of chronic hepatitis C in addiction care. Addict Sci Clin Pract, 13(1), 10. https://doi.org/10.1186/s13722-018-0111-7
   Google Scholar
• Masson, C. L., Delucchi, K. L., McKnight, C., Hettema, J., Khalili, M., Min, A., Jordan, A. E., Pepper, N., Hall, J., Hengl, N. S., Young, C., Shopshire, M. S., Manuel, J. K., Coffin, L., Hammer, H., Shapiro, B., Seewald, R. M., Bodenheimer, H. C., Jr., Sorensen, J. L., Des Jarlais, D. C., & Perlman, D. C. (2013). A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. American Journal of Public Health, 103(10), e81–e88. https://doi.org/10.2105/AJPH.2013.301458
   PubMed Web of Science ®Google Scholar
• McKnight, C., Shumway, M., Masson, C. L., Pouget, E. R., Jordan, A. E., Des Jarlais, D. C., Sorensen, J. L., & Perlman, D. C. (2017). Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. J Ethn Subst Abuse, 16(4), 404–419. https://doi.org/10.1080/15332640.2017.1292418
   PubMed Web of Science ®Google Scholar
• Miles, M. B., Huberman, A. M., & Saldana, J. (2013). Qualitative Data Analysis: A Methods Sourcebook. Sage.
   Google Scholar
• Morris, M. D., Mirzazadeh, A., Evans, J. L., Briceno, A., Coffin, P., Hahn, J. A., & Page, K. A. (2019). Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated. Drug and Alcohol Dependence, 198, 133–135. https://doi.org/10.1016/j.drugalcdep.2019.02.008
   PubMed Web of Science ®Google Scholar
• Muncan, B., Walters, S. M., Ezell, J., & Ompad, D. C. (2020). They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduction Journal, 17(1), 53. https://doi.org/10.1186/s12954-020-00399-8
   PubMed Web of Science ®Google Scholar
• Perlman, D. C., & Jordan, A. E. (2018). The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions. Current HIV/AIDS Reports, 15(2), 96–112. https://doi.org/10.1007/s11904-018-0390-3
   PubMed Web of Science ®Google Scholar
• Perlman, D. C., Jordan, A. E., & Nash, D. (2016). Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua. Frontiers in Public Health, 4, 296. https://doi.org/10.3389/fpubh.2016.00296
   PubMed Web of Science ®Google Scholar
• Phillips, L. A., & Shaw, A. (2013). Substance use more stigmatized than smoking and obesity. Journal of Substance Use, 18(4), 247–253. https://doi.org/10.3109/14659891.2012.661516
   Web of Science ®Google Scholar
• Reynoso-Vallejo, H., Chassler, D., Witas, J., & Lundgren, L. M. (2008). Patterns of drug treatment entry by Latino male injection drug users from different national/geographical backgrounds. Eval Program Plann, 31(1), 92–101. https://doi.org/10.1016/j.evalprogplan.2007.05.011
   PubMed Web of Science ®Google Scholar
• Roncero, C., Ryan, P., Littlewood, R., Macias, J., Ruiz, J., Seijo, P., Palma-Alvarez, R. F., & Vega, P. (2019). Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder. Hepatic Medicine: evidence and Research, 11, 1–11. https://doi.org/10.2147/HMER.S187133
   PubMed Web of Science ®Google Scholar
• Rosenberg, E. S., Rosenthal, E. M., Hall, E. W., Barker, L., Hofmeister, M. G., Sullivan, P. S., Dietz, P., Mermin, J., & Ryerson, A. B. (2018). Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016. JAMA Network Open, 1(8), e186371. https://doi.org/10.1001/jamanetworkopen.2018.6371
   PubMed Web of Science ®Google Scholar
• Singer, M., & Clair, S. (2003). Syndemics and public health: Reconceptualizing disease in bio-social context. Med Anthropol Q, 17(4), 423–441. https://doi.org/10.1525/maq.2003.17.4.423
   PubMed Web of Science ®Google Scholar
• Skeer, M. R., Ladin, K., Wilkins, L. E., Landy, D. M., & Stopka, T. J. (2018). ‘Hep C’s like the common cold’: understanding barriers along the HCV care continuum among young people who inject drugs. Drug and Alcohol Dependence, 190, 246–254. https://doi.org/10.1016/j.drugalcdep.2018.06.013
   PubMed Web of Science ®Google Scholar
• Tempalski, B., Friedman, R., Keem, M., Cooper, H., & Friedman, S. R. (2007). NIMBY localism and national inequitable exclusion alliances: The case of syringe exchange programs in the United States. Geoforum; Journal of Physical, Human, and Regional Geosciences, 38(6), 1250–1263. https://doi.org/10.1016/j.geoforum.2007.03.012
   PubMed Web of Science ®Google Scholar
• Valdiserri, R., Khalsa, J., Dan, C., Holmberg, S., Zibbell, J., Holtzman, D., Lubran, R., & Compton, W. (2014). Confronting the emerging epidemic of HCV infection among young injection drug users. American Journal of Public Health, 104(5), 816–821. https://doi.org/10.2105/AJPH.2013.301812
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Braksmajer, A., Coston, B., Yoon, I., Grov, C., Downing, M. J., Jr., Teran, R., & Hirshfield, S. (2020). A Syndemic Model of Exchange Sex Among HIV-Positive Men Who Have Sex With Men. Archives of Sexual Behavior, 49(6), 1965–1978. https://doi.org/10.1007/s10508-020-01628-8
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Coston, B., Neaigus, A., Rivera, A. V., Starbuck, L., Ramirez, V., Reilly, K. H., & Braunstein, S. L. (2020). The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs. The International Journal on Drug Policy, 77, 102671. https://doi.org/10.1016/j.drugpo.2020.102671
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Reilly, K. H., Neaigus, A., & Braunstein, S. (2017). Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: The importance of networks and syringe exchange programs for HIV prevention. Harm Reduction Journal, 14(1), 40. https://doi.org/10.1186/s12954-017-0166-x
   PubMedGoogle Scholar
• Walters, S. M., Seal, D. W., Stopka, T. J., Murphy, M. E., & Jenkins, W. D. (2020). COVID-19 and People Who Use Drugs - A Commentary. Health Behav Policy Rev, 7(5), 489–497. https://doi.org/10.14485/hbpr.7.5.11
   PubMed Web of Science ®Google Scholar